Verdict Hospital is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Most Read

  1. With vaccine supply stretched thin, Brazil faces yellow fever outbreak
  2. Early prostate cancer diagnosis: can Theresa May’s plan mimic results in Japan?
  3. Burden of chronic lymphocytic leukemia is disproportionately higher in men
  4. Adolescent depressive episodes are increasing in the US, but treatment is lacking
  5. FDA approves 23andMe at-home genetic test for breast cancer genes

Latest Content

Early prostate cancer diagnosis: can Theresa May’s plan mimic results in Japan?

On April 10, 2018, UK Prime Minister Theresa May announced a £75M (approximately $106M) investment into prostate cancer diagnosis and research. The plan aims to focus on early diagnosis in men in high-risk groups, including black men, men ages 50 and over, and men with a family history of the disease. The UK appears to be following the lead of Japan, where prostate cancer is typically diagnosed at an earlier stage compared with the other markets analysed by GlobalData.

The ageing population is at a greater risk of osteoporosis

Osteoporosis is a disease in which the density and quality of bone are reduced over time. Osteoporosis is often referred to as a ‘silent’ disease as the loss of bone occurs progressively, and often there are no symptoms until the first fracture occurs.

Burden of chronic lymphocytic leukemia is disproportionately higher in men

The burden of chronic lymphocytic leukaemia (CLL) is expected to grow in both men and women, ages 18 years and older, between 2015 and 2025 in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Canada). GlobalData epidemiologists forecast an increase in the number of diagnosed incident cases, most notably in men. Figure 1 presents the sex-specific cases of CLL in the 7MM in 2015.

Latest News

Go Top